Pharmaceutical Commerce: April 2025 Interactive Digital Edition

Publication
Article
Pharmaceutical CommercePharmaceutical Commerce - April 2025
Volume 20
Issue 2

View the Pharmaceutical Commerce April 2025 issue in an interactive format.

Click here to view our interactive April 2025 issue!

Download Issue PDF
Articles in this issue
Pharmaceutical Commerce: April 2025 Interactive Digital Edition
Pharmaceutical Commerce: April 2025 Interactive Digital Edition
The Cold Chain's Evolution
The Cold Chain's Evolution
Tariffs Galore: Where Do We Stand?
Tariffs Galore: Where Do We Stand?
Conference Connect: Progressing Patient Assistance
Conference Connect: Progressing Patient Assistance
The Hot Market for Cold Chain Services
The Hot Market for Cold Chain Services
Reducing Risk in the Pharmaceutical Cold Chain
Reducing Risk in the Pharmaceutical Cold Chain
An AI-Pharma Transport Collaboration
An AI-Pharma Transport Collaboration
The Role of CDMOs in the Pharma Cold Chain Machine
The Role of CDMOs in the Pharma Cold Chain Machine
From Prescription to Patient: Four Ways to Increase Speed to Therapy
From Prescription to Patient: Four Ways to Increase Speed to Therapy
What Your Data Can Tell You About Illicit Trade Risk
What Your Data Can Tell You About Illicit Trade Risk
Healthcare Scorecard from Patients with Chronic Illness
Healthcare Scorecard from Patients with Chronic Illness
Popping the Gross-to-Net Bubble, Part III: The Pharmacy Benefit
Popping the Gross-to-Net Bubble, Part III: The Pharmacy Benefit
US Drug Price Negotiations and Transparency
US Drug Price Negotiations and Transparency
Strategies to Modernize, Future-Proof, and Secure the Healthcare Supply Chain
Strategies to Modernize, Future-Proof, and Secure the Healthcare Supply Chain
Maintaining R&D Investments in the IRA Era
Maintaining R&D Investments in the IRA Era
Recent Videos
Related Content
Hikma Commits $1 Billion to Boost US Drug Manufacturing and R&D Services by 2030

Hikma Commits $1 Billion to Boost US Drug Manufacturing and R&D Services by 2030

Nicholas Saraceno, Editor
July 3rd 2025
Article

The company joins a wave of global pharma companies reshoring operations to strengthen the US supply chain and meet patient needs through domestic innovation and capacity.

How Recent Executive Orders Impact the Drug Pricing Landscape

How Recent Executive Orders Impact the Drug Pricing Landscape

Nicholas Saraceno, Editor
May 30th 2025
Podcast

Alice Valder Curran outlines the steps manufacturers should take to better prepare for upcoming executive actions on drug pricing and market access.

Pharma Pulse 7/2/25: The Impact of FDA’s Ban on Compounded GLP-1s; How Sites and Sponsors Are Adapting to Clinical Trial Budget Cuts

Pharma Pulse 7/2/25: The Impact of FDA’s Ban on Compounded GLP-1s; How Sites and Sponsors Are Adapting to Clinical Trial Budget Cuts

Don Tracy, Associate Editor
July 2nd 2025
Article
Fast-Tracking the Future

Fast-Tracking the Future

Nicholas Saraceno, Editor;Don Tracy, Associate Editor
April 25th 2025
Podcast

Claire Riches highlights inefficiencies in the current drug approval process, while outlining the role of payers and insurers in shifting toward data-driven approval framework.

Pharma Pulse 7/1/25: Oncology Care Index Spurs J&J to Address Fragmentation in Cancer Treatment; How Funding Cuts Are Undermining Patient Recruitment in Clinical Trials

Pharma Pulse 7/1/25: Oncology Care Index Spurs J&J to Address Fragmentation in Cancer Treatment; How Funding Cuts Are Undermining Patient Recruitment in Clinical Trials

Don Tracy, Associate Editor
July 1st 2025
Article

Novo Nordisk Expands Wegovy Access Through New WeightWatchers Partnership

Novo Nordisk Expands Wegovy Access Through New WeightWatchers Partnership

Nicholas Saraceno, Editor
June 30th 2025
Article

Access to the GLP-1 will be streamlined, and starting July 1, will result in a limited-time $299 price for eligible self-pay patients.

© 2025 MJH Life Sciences

All rights reserved.